Literature DB >> 16505070

Rapid recovery from acute transverse myelitis in an elite female swimmer.

G Dubnov1, N W Constantini.   

Abstract

Rubella is now an uncommon disease, and its neurological complications are rarely encountered. One complication, acute transverse myelitis, has been described in a few case reports and usually has an unfavourable outcome. The case is presented of an elite swimmer who developed transverse myelitis after rubella, which was treated with methylprednisolone. The recovery was so rapid and complete that two months after the acute event she broke a national swimming record.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16505070      PMCID： PMC2491982          DOI： 10.1136/bjsm.2005.020685

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN： 0306-3674            Impact factor:   13.800


  6 in total

1.  [Acute transverse myelitis after rubella infection in an adult].

Authors:  J Hess; S Bamborschke
Journal:  Nervenarzt       Date:  1993-04       Impact factor: 1.214

2.  Acute transverse myelitis. A localized form of postinfectious encephalomyelitis.

Authors:  S M al Deeb; B A Yaqub; G W Bruyn; N M Biary
Journal:  Brain       Date:  1997-07       Impact factor: 13.501

3.  High dose methylprednisolone in severe acute transverse myelopathy.

Authors:  G Sébire; H Hollenberg; L Meyer; G Huault; P Landrieu; M Tardieu
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

4.  [A case report of post-rubella myelitis in an adult].

Authors:  A Cecille; H Schuster; Y Hansmann; M J Wendling; D Christmann; J P Gut
Journal:  Pathol Biol (Paris)       Date:  1999-05

5.  [A case of acute transverse myelitis following rubella].

Authors:  M Koike; Y Osuga; Y Suzuki; K Hagimoto; H Ishida; S Shimojo
Journal:  Nihon Naika Gakkai Zasshi       Date:  1995-05-10

6.  Neurological complications following rubella infection.

Authors:  M Bechar; S Davidovich; G Goldhammer; I Machtey; N Gadoth
Journal:  J Neurol       Date:  1982       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.